Skip to main content

Search

St. Louis Anthropocene: displacement & replacement

JJP

A brief essay about St. Louis' notorious eminent domain history--

--along with 2 recent St. Louis Post-Dispatch articles about "urban renewal" projects that are scheduled to reoccupy the Mill Flats area, which hosted the most notorious episode of displacement of African-American communities: the Chouteau Greenway project (will it serve or displace low-income St. Louisans?); and SLU's Mill Creek Flats high-rise project, which certainly will, and whose name seems to me an especially tone-deaf if gutsy move...

https://humanities.wustl.edu/features/Margaret-Garb-St-Louis-Eminent-Domain

https://www.stltoday.com/business/local/steelcote-developer-plans-more-apartments-brewery-space-in-million-midtown/article_811eaf96-76e1-5c20-a870-1e79abd3f06e.html

https://www.stltoday.com/business/local/chouteau-greenway-project-aims-to-knit-st-louis-neighborhoods-together/article_55fea4e6-6829-5c80-9168-313305b4e3bb.html

pece_annotation_1473995548

tamar.rogoszinski
  1. I first looked up travel to and from Liberia during the Ebola outbreak, since it had been seized. There was a ban, which has since been lifted after, but people coming to and from West Africa are still screened and recommended to visit physicians. As of mid-2015 there wa still a 21 day monitoring period needed. http://www.infectioncontroltoday.com/news/2015/05/cdc-downgrades-travel…'
  2. I was interested if there had been any progress on treatment for Ebola, but found that the main form of treatment is supportive care. Doctors are informed to provide IV fluid and ensure that the patient's immune response and other bodily functions are functioning properly. A vaccine is being worked on but has not gone through a trial to prove safety and effectiveness. https://www.cdc.gov/vhf/ebola/treatment/index.html
  3. I looked further into the vaccine being produced for Ebola. Currently, there is a combined phase 2 and phase 3 trial occurring in Sierra Leone called STRIVE (Sierra Leone Trial to Introduce a Vaccine against Ebola). The study is unblinded, so patients know whether or not they have received the vaccine. The vaccine is a rVSV-ZEBOV, or recombinant Vesicular Stomatitis Virus Zaire ebolavirus vaccine. This vaccine is also being used in phase 2 and phase 3 trials in Guinea and Liberia http://www.cdc.gov/vhf/ebola/strive/qa.html

pece_annotation_1475202196

tamar.rogoszinski

The convention in 1951 was a response to WW2 and the vast amounts of refugees that existed as a result. States involved in the convention and the UN could decide to apply it to refugees not necessarily from WW2, but in 1967, the limits were removed and made it so that it could apply to any refugees, not just those from WW2. It has since been used during major refugee crises in Africa, the Middle East, and Asia.